These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16432449)

  • 1. The new arms race against melanoma.
    Lejeune FJ
    Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma.
    Nickoloff BJ; Vande Woude G
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):758-61. PubMed ID: 22974232
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer research. Melanoma drug vindicates targeted approach.
    Garber K
    Science; 2009 Dec; 326(5960):1619. PubMed ID: 20019269
    [No Abstract]   [Full Text] [Related]  

  • 4. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF inhibitors: research accelerates in wake of positive findings.
    Brower V
    J Natl Cancer Inst; 2010 Feb; 102(4):214-5. PubMed ID: 20145213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Update on BRAF and MEK inhibitors in the treatment of malignant melanoma].
    Gutzmer R
    J Dtsch Dermatol Ges; 2015 May; 13(5):485-7. PubMed ID: 25918105
    [No Abstract]   [Full Text] [Related]  

  • 7. Fisetin: a natural fist against melanoma?
    Arbiser JL; Fisher DE
    J Invest Dermatol; 2011 Jun; 131(6):1187-9. PubMed ID: 21566577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Madhunapantula SV; Robertson GP
    Cancer Res; 2008 Jan; 68(1):5-8. PubMed ID: 18172288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance.
    Alcalá AM; Flaherty KT
    Clin Cancer Res; 2012 Jan; 18(1):33-9. PubMed ID: 22215904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brothers RAF.
    Kwong LN; Chin L
    Cell; 2010 Jan; 140(2):180-2. PubMed ID: 20141832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene abnormalities in melanoma and signal transduction antagonists].
    Takada M
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):453-7. PubMed ID: 23894754
    [No Abstract]   [Full Text] [Related]  

  • 12. c-Met is a potentially new therapeutic target for treatment of human melanoma.
    Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
    Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma: molecular cytogenetics and their implications in clinical medicine.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2010 Aug; 63(2):329-32. PubMed ID: 20633801
    [No Abstract]   [Full Text] [Related]  

  • 14. Feeling energetic? New strategies to prevent metabolic reprogramming in melanoma.
    Verduzco D; Flaherty KT; Smalley KS
    Exp Dermatol; 2015 Sep; 24(9):657-8. PubMed ID: 26010519
    [No Abstract]   [Full Text] [Related]  

  • 15. Nivolumab success in untreated metastatic melanoma.
    Wilkinson E
    Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638562
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming melanoma drug resistance through metabolic targeting?
    Smalley KS
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):793-5. PubMed ID: 24152044
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for the Achilles' heel of melanoma cells: new treatment modalities.
    Melnikova VO; Bar-Eli M
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):505-6. PubMed ID: 18713130
    [No Abstract]   [Full Text] [Related]  

  • 19. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting growth factors and angiogenesis; using small molecules in malignancy.
    Wanebo HJ; Argiris A; Bergsland E; Agarwala S; Rugo H
    Cancer Metastasis Rev; 2006 Jun; 25(2):279-92. PubMed ID: 16770540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.